ClinicalTrials.gov
public full text
Public Domain
A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
alzheimeralzheimer-diseasealzheimer-s-diseaseclinical-trialdementiadiabetesdietary-supplementstherapeutics
The purpose of this study is to evaluate the safety and efficacy of NIC5-15 in the treatment of Alzheimer's Disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Non-invasive Stimulation in Neurofibromatosis Type 1#1111727
- DEMENTIA#1043483
- DEMENTIA#1043470
- An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease#915777
- A Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients with Alzheimer's Disease.#1382680
Record · ID 1421091
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive